Will someone please look at page 22 of the fda briefing doc and explain to me how any of that data would intimate that sppi's drug has evokes less pain than the placebo.
the GI side effects of the drug are pretty harsh at double the rate of placebo
what was the pain score used. I think that is the issue the fda has.
Market Data 
Markets 
AI
